KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Long-Term Investments (2017 - 2018)

Elanco Animal Health (ELAN) has disclosed Long-Term Investments for 2 consecutive years, with $15.3 million as the latest value for Q4 2018.

  • Quarterly Long-Term Investments rose 24.39% to $15.3 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $15.3 million through Dec 2018, up 24.39% year-over-year, with the annual reading at $15.3 million for FY2018, 24.39% up from the prior year.
  • Long-Term Investments hit $15.3 million in Q4 2018 for Elanco Animal Health, up from $14.9 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $15.3 million in Q4 2018 to a low of $12.3 million in Q4 2017.